Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
GZPHF
$2.35
-$0.015-0.64%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -1.09% | -3.78% | -2.46% | 0.67% | 0.17% |
| Total Other Revenue | 13.69% | -12.74% | -12.74% | -2.87% | -13.84% |
| Total Revenue | -1.05% | -3.81% | -2.50% | 0.66% | 0.12% |
| Cost of Revenue | 0.76% | -1.01% | 0.09% | 3.26% | 1.52% |
| Gross Profit | -9.43% | -16.15% | -13.67% | -10.41% | -5.86% |
| SG&A Expenses | -4.49% | -10.53% | -7.55% | -9.37% | -3.80% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 361.61% | 232.99% | 503.32% | -4,677.27% | -237.74% |
| Total Operating Expenses | 0.50% | -1.94% | -0.80% | 1.51% | 0.55% |
| Operating Income | -25.65% | -31.21% | -27.22% | -11.80% | -6.21% |
| Income Before Tax | -28.22% | -35.80% | -31.26% | -20.47% | -12.15% |
| Income Tax Expenses | -30.51% | -37.67% | -30.61% | -14.01% | -6.24% |
| Earnings from Continuing Operations | -27.77% | -35.42% | -31.39% | -21.68% | -13.24% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 49.73% | 41.64% | 20.47% | 10.43% | 14.35% |
| Net Income | -26.54% | -35.09% | -31.93% | -22.24% | -13.18% |
| EBIT | -25.65% | -31.21% | -27.22% | -11.80% | -6.21% |
| EBITDA | -22.93% | -28.23% | -23.93% | -9.29% | -4.47% |
| EPS Basic | -26.51% | -35.08% | -31.95% | -22.25% | -13.22% |
| Normalized Basic EPS | -25.44% | -29.85% | -26.52% | -19.27% | -11.53% |
| EPS Diluted | -26.51% | -35.08% | -31.95% | -22.25% | -13.22% |
| Normalized Diluted EPS | -25.44% | -29.85% | -26.52% | -19.27% | -11.53% |
| Average Basic Shares Outstanding | 0.00% | 0.01% | 0.02% | -0.01% | -0.02% |
| Average Diluted Shares Outstanding | 0.00% | 0.01% | 0.02% | -0.01% | -0.02% |
| Dividend Per Share | -30.21% | 6.85% | 6.85% | 54.27% | 54.27% |
| Payout Ratio | 0.52% | 1.17% | 1.04% | 0.28% | 0.14% |